Hpb最新文献

筛选
英文 中文
Using cell-free DNA tumor methylation score to detect and monitor cholangiocarcinoma 应用游离DNA肿瘤甲基化评分检测和监测胆管癌。
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 Epub Date: 2026-05-19 DOI: 10.1016/j.hpb.2026.05.004
Salar Javanshir, Isabella Angeli-Pahim, Pavan Iyengar, Anastasia Chambers, Iulia M. Smarandache, Rishiraj Ganguli, Abhishek Shrestha, Jessica Squadrito, Adriana Abreu, Gabrielle Suchan, Carl Rizk, Fahreddin Palaz, Steven J. Hughes, Ilyas Sahin, Joseph R. Grajo, Sergio Duarte, Ali Zarrinpar
{"title":"Using cell-free DNA tumor methylation score to detect and monitor cholangiocarcinoma","authors":"Salar Javanshir,&nbsp;Isabella Angeli-Pahim,&nbsp;Pavan Iyengar,&nbsp;Anastasia Chambers,&nbsp;Iulia M. Smarandache,&nbsp;Rishiraj Ganguli,&nbsp;Abhishek Shrestha,&nbsp;Jessica Squadrito,&nbsp;Adriana Abreu,&nbsp;Gabrielle Suchan,&nbsp;Carl Rizk,&nbsp;Fahreddin Palaz,&nbsp;Steven J. Hughes,&nbsp;Ilyas Sahin,&nbsp;Joseph R. Grajo,&nbsp;Sergio Duarte,&nbsp;Ali Zarrinpar","doi":"10.1016/j.hpb.2026.05.004","DOIUrl":"10.1016/j.hpb.2026.05.004","url":null,"abstract":"<div><h3>Background</h3><div>Cholangiocarcinoma (CCA) is characterized by late or unclear diagnosis, high recurrence rates, and limited options for noninvasive disease monitoring. The widely used serum biomarker CA 19-9 has suboptimal sensitivity and specificity, underscoring the need for more accurate and reliable quantitative measures of tumor burden. Cell-free DNA (cfDNA) methylation represents a promising approach for longitudinal disease monitoring.</div></div><div><h3>Methods</h3><div>In this single-center cohort study, we evaluated a cfDNA methylation-based Tumor Methylation Score (TMS) for detecting and monitoring CCA. Twenty-five patients with histologically confirmed CCA and twelve controls with benign hepatobiliary conditions were enrolled, yielding 100 plasma samples and 26 tissue samples. cfDNA methylation was quantified across 537 cancer-associated CpG loci by qPCR method, and TMS was calculated from the difference in methylation in paired plasma and buffy coat samples. For tissue samples, TMS was calculated by quantifying methylation in tumor and background liver separately. Response to treatment was assessed using blinded radiographic review. Tissue-based validation was performed using The Cancer Genome Atlas and 4 additional GEO cohorts. Finally, cellular pathways associated with the panel genes were explored using the Ingenuity Pathway Analysis (IPA).</div></div><div><h3>Results</h3><div>TMS was significantly elevated in CCA samples compared with controls in both tissue (P = 0.007) and plasma (P &lt; 0.0001). Plasma TMS distinguished CCA from controls with a sensitivity of 74.3% and specificity of 80% (AUC = 0.823), while CA 19-9 showed no discriminatory value. TMS decreased consistently following curative resection. Longitudinal changes in TMS (ΔTMS) robustly distinguished radiographic progression from non-progression during systemic therapy (AUC = 0.968), outperforming ΔCA 19–9. Tissue-based analyses across independent cohorts confirmed cancer specificity and association with adverse outcomes. IPA identified HOXA9 as a significantly altered gene implicated in CCA carcinogenesis.</div></div><div><h3>Conclusions</h3><div>Quantitative cfDNA methylation monitoring using TMS is feasible and accurately reflects dynamic tumor burden in CCA. TMS may serve as a complementary adjunct to imaging and CA 19–9 for diagnosis, prognosis, and longitudinal disease monitoring, warranting validation in larger prospective studies.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Pages 1125-1135"},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148204567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Board / Aims and Scope 编辑委员会/目标和范围
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 Epub Date: 2026-08-05 DOI: 10.1016/S1365-182X(26)00704-5
{"title":"Editorial Board / Aims and Scope","authors":"","doi":"10.1016/S1365-182X(26)00704-5","DOIUrl":"10.1016/S1365-182X(26)00704-5","url":null,"abstract":"","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Page IFC"},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148666666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpretation of the predictive value of drain fluid amylase in patients with trans-anastomotic stents. 引流液淀粉酶对经吻合口支架患者预测价值的解释。
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 DOI: 10.1016/j.hpb.2026.07.010
Takehiko Hanaki
{"title":"Interpretation of the predictive value of drain fluid amylase in patients with trans-anastomotic stents.","authors":"Takehiko Hanaki","doi":"10.1016/j.hpb.2026.07.010","DOIUrl":"https://doi.org/10.1016/j.hpb.2026.07.010","url":null,"abstract":"","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148761249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IHPBA news 1 IHPBA新闻
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 Epub Date: 2026-08-05 DOI: 10.1016/S1365-182X(26)00708-2
{"title":"IHPBA news 1","authors":"","doi":"10.1016/S1365-182X(26)00708-2","DOIUrl":"10.1016/S1365-182X(26)00708-2","url":null,"abstract":"","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Page IBC"},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148666832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The E-AHPBA – ESSO – Innsbruck consensus recommendations on peri- and postoperative management following liver resection E-AHPBA - ESSO - Innsbruck关于肝切除术后围期和术后处理的共识建议。
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 Epub Date: 2025-11-13 DOI: 10.1016/j.hpb.2025.10.008
Eva Maier, Stefan Stättner, Lucia Carrion-Alvarez, Marcello Di Martino, Pim Olthof, Florian Primavesi, Dana Sochorova, Stijn van Laarhoven, Anita Balakrishnan, Robert Breitkopf, Carlijn I. Buis, Federica Cipriani, Joris Erdmann, Adam Frampton, David Fuks, Stefan Gilg, Aiste Gulla, Francesco Lancellotti, Christian Margreiter, Emmanuel Melloul, Manuel Maglione
{"title":"The E-AHPBA – ESSO – Innsbruck consensus recommendations on peri- and postoperative management following liver resection","authors":"Eva Maier,&nbsp;Stefan Stättner,&nbsp;Lucia Carrion-Alvarez,&nbsp;Marcello Di Martino,&nbsp;Pim Olthof,&nbsp;Florian Primavesi,&nbsp;Dana Sochorova,&nbsp;Stijn van Laarhoven,&nbsp;Anita Balakrishnan,&nbsp;Robert Breitkopf,&nbsp;Carlijn I. Buis,&nbsp;Federica Cipriani,&nbsp;Joris Erdmann,&nbsp;Adam Frampton,&nbsp;David Fuks,&nbsp;Stefan Gilg,&nbsp;Aiste Gulla,&nbsp;Francesco Lancellotti,&nbsp;Christian Margreiter,&nbsp;Emmanuel Melloul,&nbsp;Manuel Maglione","doi":"10.1016/j.hpb.2025.10.008","DOIUrl":"10.1016/j.hpb.2025.10.008","url":null,"abstract":"<div><h3>Background</h3><div>Liver surgery carries a high risk of complications due to the interplay of patient-related factors, disease characteristics and liver function. This European consensus provides evidence-based guidance on selected aspects of perioperative care.</div></div><div><h3>Methods</h3><div>A modified Delphi process was used to achieve consensus, with a 70 % agreement threshold. The expert panel comprised hepatobiliary surgeons, anaesthetists, hepatologists, a nurse and physiotherapist. Systematic literature search was conducted in PubMed/Medline, EMBASE, Web of Science, and Cochrane databases. Evidence appraisal and statement development followed Scottish Intercollegiate Guidelines Network methodology.</div></div><div><h3>Results</h3><div>Six topics were addressed: (i) thromboprophylaxis, (ii) antibiotics, (iii) prehabilitation-nutrition-mobilisation, (iv) bile leaks, including bilio-enteric anastomosis, (v) post-hepatectomy haemorrhage, (vi) post-hepatectomy liver failure (PHLF). Screening yielded <em>204</em> included publications (initial <em>6514) and</em> thirty-two statements were formulated (median evidence-level:2). Evidence strength varied by topic with lower evidence-levels in complex surgery settings and subcohorts. Study heterogeneity and specific inclusion criteria resulted in some topics in conditional recommendations despite high-level evidence. Weakest evidence was found for thromboprophylaxis and PHLF managment. Strong recommendations were formulated for prehabilitation, mobilisation, and avoidance of routine drainage. Several evidence gaps warranting multicentre studies were identified.</div></div><div><h3>Conclusion</h3><div>Optimising perioperative care after hepatectomy remains challenging. Standardising key practices and addressing evidence gaps through collaborative research are vital to improve outcomes.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Pages 1005-1033"},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145523277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omitted variable bias and validation circularity: a computational audit of the APHPBA score 省略变量偏差和验证循环:对appba评分的计算审计。
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 Epub Date: 2026-04-14 DOI: 10.1016/j.hpb.2026.04.449
Xiangbo Ma, Wei Li
{"title":"Omitted variable bias and validation circularity: a computational audit of the APHPBA score","authors":"Xiangbo Ma,&nbsp;Wei Li","doi":"10.1016/j.hpb.2026.04.449","DOIUrl":"10.1016/j.hpb.2026.04.449","url":null,"abstract":"","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Page 1147"},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148042173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practice patterns and implementation of combined ablation and resection (CARe) strategies for colorectal liver metastases: a pan-European survey 结直肠癌肝转移的联合消融和切除(CARe)策略的实践模式和实施:一项泛欧调查。
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 Epub Date: 2026-04-01 DOI: 10.1016/j.hpb.2026.03.007
Gabriela Pilz da Cunha, Hannah H. Schulz, Niels F.M. Kok, Martijn R. Meijerink, Rutger-Jan Swijnenburg
{"title":"Practice patterns and implementation of combined ablation and resection (CARe) strategies for colorectal liver metastases: a pan-European survey","authors":"Gabriela Pilz da Cunha,&nbsp;Hannah H. Schulz,&nbsp;Niels F.M. Kok,&nbsp;Martijn R. Meijerink,&nbsp;Rutger-Jan Swijnenburg","doi":"10.1016/j.hpb.2026.03.007","DOIUrl":"10.1016/j.hpb.2026.03.007","url":null,"abstract":"<div><h3>Background</h3><div>Combined ablation and resection (CARe) is a parenchymal sparing alternative to more extensive liver resection in selected patients with colorectal liver metastases (CRLM). This study aims to characterize the degree of implementation of CARe and approaches across Europe.</div></div><div><h3>Methods</h3><div>An online survey was conducted among members of the European-African Hepato-Pancreato-Biliary Association, between June and August 2025, to assess current CARe practice patterns, including implementation, strategies, and clinician perspectives.</div></div><div><h3>Results</h3><div>Overall, 91 responses from 77 centres across 23 countries were analysed. The majority of respondents worked at university hospitals (81%). 91% of centres indicated that CARe is available at their institution, though most centres (65%) report using CARe in ≤20% of resections. Neither high institutional ablation nor high resection volumes were significantly associated with CARe implementation, although a trend was observed for ablation volume (p = 0.068). Minimally invasive CARe approaches are adopted in the majority (89%) of centres performing CARe, including both ultrasound guided (percutaneous (59%) or laparoscopic (73%)) and CT-guided techniques (54%), performed intraoperatively or in sequential sessions. Notably, despite the parenchymal sparing potential of CARe, 20% of respondents indicated a preference for major hepatectomy when both strategies could achieve complete tumour clearance.</div></div><div><h3>Conclusion</h3><div>Although widely available among responding centres, substantial variation in institutional implementation and strategies for CARe, highlight the need for evidence-based best practice recommendations and training programs for ablation.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Pages 1052-1063"},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147959931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current status of split liver transplantation using machine perfusion in the United States 美国机器灌注分离式肝移植的现状
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 Epub Date: 2026-05-06 DOI: 10.1016/j.hpb.2026.04.465
Toshihiro Nakayama, Ryo Ito, Antony Attia, Daniel J. Ahn, Hirofumi Ichida, Shinnosuke Shiraki, Kazunari Sasaki
{"title":"Current status of split liver transplantation using machine perfusion in the United States","authors":"Toshihiro Nakayama,&nbsp;Ryo Ito,&nbsp;Antony Attia,&nbsp;Daniel J. Ahn,&nbsp;Hirofumi Ichida,&nbsp;Shinnosuke Shiraki,&nbsp;Kazunari Sasaki","doi":"10.1016/j.hpb.2026.04.465","DOIUrl":"10.1016/j.hpb.2026.04.465","url":null,"abstract":"","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Pages 1143-1146"},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147972130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Board / Aims and Scope 编辑委员会/目标和范围
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 Epub Date: 2026-08-05 DOI: 10.1016/S1365-182X(26)00704-5
{"title":"Editorial Board / Aims and Scope","authors":"","doi":"10.1016/S1365-182X(26)00704-5","DOIUrl":"10.1016/S1365-182X(26)00704-5","url":null,"abstract":"","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Page IFC"},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148666672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IHPBA news 2 IHPBA新闻2。
IF 3.3 3区 医学
Hpb Pub Date : 2026-08-01 Epub Date: 2026-08-05 DOI: 10.1016/S1365-182X(26)00709-4
{"title":"IHPBA news 2","authors":"","doi":"10.1016/S1365-182X(26)00709-4","DOIUrl":"10.1016/S1365-182X(26)00709-4","url":null,"abstract":"","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"28 8","pages":"Page OBC"},"PeriodicalIF":3.3,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148666675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书